Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
Memorial Sloan Kettering Cancer Center · Kettering University · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
99
total citations
- FWCI
- 61.01
- Percentile
- 100%
- References
- 52
Citations per year
Authors
17- VTViviane TabarCorresponding
Memorial Sloan Kettering Cancer Center, Kettering University
- HSHarini Sarva
Cornell University, Weill Cornell Medicine
- AMAndrés M. Lozano
University of Toronto, Ontario Brain Institute, Krembil Brain Institute
- AFAlfonso Fasano
University of Toronto, Toronto Western Hospital, Ontario Brain Institute, Krembil Brain Institute
- SKSuneil K. Kalia
University of Toronto, Ontario Brain Institute, Krembil Brain Institute
Topics & keywords
Topics
Keywords
- Dopaminergic
- Medicine
- Tolerability
- Transplantation
- Putamen
- Clinical trial
- Parkinson's disease
- Cell therapy
No related works found for this paper.